Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1996
11/07/1996WO1996034953A2 Cd16-ii variants
11/07/1996WO1996034943A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
11/07/1996WO1996034940A1 Dna encoding glutamate gated chloride channels
11/07/1996WO1996034891A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996WO1996034876A1 Nucleic acid ligand complexes
11/07/1996WO1996034870A1 Azacycloalcane derivatives, preparation thereof and their applications in therapy
11/07/1996WO1996034869A1 Esters of carbapenems
11/07/1996WO1996034868A1 Esters of carbapenems
11/07/1996WO1996034867A1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
11/07/1996WO1996034866A1 Imidazo 1,2-a pyridine and imidazo 1,2-a pyridezine derivatives and their use as bone resorption inhibitors
11/07/1996WO1996034865A1 Novel heterocyclic chemistry
11/07/1996WO1996034864A1 Piperazino derivatives as neurokinin antagonists
11/07/1996WO1996034863A1 Novel heterocyclic chemistry
11/07/1996WO1996034858A1 Nicotinic acid esters and pharmaceutical compositions containing them
11/07/1996WO1996034857A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
11/07/1996WO1996034856A1 2-ureido-benzamide derivatives
11/07/1996WO1996034855A1 Fatty acid esters as bioactive compounds
11/07/1996WO1996034852A1 Novel tetracycline derivatives
11/07/1996WO1996034849A1 Tetralines bearing a phenyl substituant on the aromatic ring and their use in the treatment of epilepsy, stroke and brain or spinal trauma
11/07/1996WO1996034846A1 1,3-propane diol derivatives as bioactive compounds
11/07/1996WO1996034629A1 Method and composition for prevention of posterior capsule opacification
11/07/1996WO1996034622A1 Modified myelin protein molecules
11/07/1996WO1996034611A1 Methods to inhibit late radiation-induced skin damage
11/07/1996WO1996034610A1 Methods to inhibit acute radiation-induced skin damage
11/07/1996WO1996034608A1 Oral lubricating composition comprising a beta-glucan
11/07/1996WO1996034607A1 Combined preparations with vascular effect containing dihydropyridines, acetylsalicylic acid nitroesters and vitamins
11/07/1996WO1996034606A1 Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
11/07/1996WO1996034605A1 Composition comprising amoxycillin and clavulanic acid
11/07/1996WO1996034604A1 Inhibition of intracellular acidification
11/07/1996WO1996034602A1 Methods of inhibition or killing of cancer cells
11/07/1996WO1996034601A1 Treatment of psoriasis with 11-cis-retinoic acid
11/07/1996WO1996034600A1 Beta-agonists as an aid to maintain or enhance strength and endurance
11/07/1996WO1996034599A1 Prolonged nerve blockage by the combination of local anesthetics and glucocorticoids
11/07/1996WO1996034583A1 Method and compositions for treating impotence
11/07/1996WO1996034526A1 Compositions and methods for stimulating hair growth
11/07/1996WO1996034525A1 Inducement of thermotolerance with benzoquinonoid ansamycins
11/07/1996WO1996027664A3 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof
11/07/1996WO1996027369A3 Compositions for the treatment of blood disorders
11/07/1996EP0751760A4 Method for the treatment and/or prevention of radiation burn
11/07/1996DE4447287C1 Droplet-in-fluid composition to transport agent e.g. through skin
11/07/1996DE19515971A1 Kombinationspräparate mit vaskulärer Wirkung Combination products with vascular effect
11/07/1996CA2220180A1 Prolonged nerve blockage by the combination of local anesthetics and glucocorticoids
11/07/1996CA2220156A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
11/07/1996CA2220123A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996CA2220015A1 Azacycloalcane derivatives, preparation thereof and their applications in therapy
11/07/1996CA2219936A1 Vasoactive intestinal peptide
11/07/1996CA2219277A1 Novel tetracycline derivatives
11/07/1996CA2218858A1 Modified myelin protein molecules
11/07/1996CA2218523A1 Inducement of thermotolerance with benzoquinonoid ansamycins
11/07/1996CA2218034A1 Pancreas-derived serpin
11/07/1996CA2217990A1 Esters of carbapenems
11/07/1996CA2217885A1 Esters of carbapenems
11/07/1996CA2216377A1 Methods to inhibit acute radiation-induced skin damage
11/07/1996CA2208666A1 Method and compositions for treating impotence
11/07/1996CA2194481A1 2-ureido-benzamide derivatives
11/06/1996EP0741139A1 Sulphuric acid esters of amino sugars
11/06/1996EP0741133A2 Adhesion receptor antagonists
11/06/1996EP0741128A2 Sulphuric acid esters of sugar alcohols for the inhibition of the migration and proliferation of smooth muscle cells of the vascular walls
11/06/1996EP0740940A2 Process for disinfecting musculoskeletal tissue and tissues prepared thereby
11/06/1996EP0740938A2 Proline and 4-hydroxyproline as therapeutic agents
11/06/1996EP0740937A2 Use of retinoids for the manufacture of a pharmaceutical or cosmetic composition
11/06/1996EP0740936A2 Use of benzopyran derivatives for the manufacture of medicaments for the treatment of diseases connected with the sodium independent Cl-/HCO3- exchanger
11/06/1996EP0740935A1 Analgesic activity enhancer
11/06/1996EP0740934A1 Controlled release pharmaceutical compositions and method for preparing them
11/06/1996EP0740708A1 Design of drugs involving receptor-ligand-dna interactions
11/06/1996EP0740704A1 Immunization by inoculation of dna transcription unit
11/06/1996EP0740679A1 Crosslinked polymeric ammonium salts
11/06/1996EP0740668A1 Tetracyclic derivatives, process of preparation and use
11/06/1996EP0740667A1 Process and intermediates for preparing naphthyridonecarboxylic acid salts
11/06/1996EP0740658A1 N-substituted azabicycloheptane derivatives used, for example, as neuroleptics
11/06/1996EP0740657A1 4-arylisoindole analgesics
11/06/1996EP0740655A1 Metalloproteinase inhibitors
11/06/1996EP0740654A1 Monoamine oxidase b inhibitors, processes for their preparation and use thereof
11/06/1996EP0740653A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
11/06/1996EP0740652A1 Metalloproteinase inhibitors
11/06/1996EP0740650A1 Codrugs as a method of controlled drug delivery
11/06/1996EP0740649A1 Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure
11/06/1996EP0740551A1 Vanadate compounds for the treatment of proliferative disorders, metastases and drug resistant tumors
11/06/1996EP0740550A1 Use of mometasone furoate for treating airway passage and lung diseases
11/06/1996EP0740549A1 Cis-hydroxyproline analogs for eye treatment
11/06/1996EP0740546A1 Oral composition
11/06/1996EP0727996A4 Fenbendazole formulations
11/06/1996EP0675712A4 Reduction of hair growth employing sulfhydryl reactive compounds.
11/06/1996EP0641760B1 Phenylalkanoic acid derivative, production thereof, and separation of optical isomers thereof
11/06/1996EP0580642B1 Aminoacyl derivatives of gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them
11/06/1996EP0532629B1 1-piperidinyl alkanoylarylsulfonamide derivatives
11/06/1996CN1135237A Products that elicit neutralizing antibodies against genetically divergent HIV-1 strains
11/06/1996CN1135232A Antioxidant-containing blowing agent
11/06/1996CN1135221A Urethane-containing aminosteroid compounds
11/06/1996CN1135219A Anthracycline derivatives
11/06/1996CN1135218A Piperidine derivatives
11/06/1996CN1135216A Optically active imidazolidinone derivative and process for prodn. of same
11/06/1996CN1135215A Imidazolidinone derivative, acid-addition salt therefor, and remedy for senile dementia
11/06/1996CN1135209A Novel phenylalkylaminoalcohol carbamates and process for prepn. of same
11/06/1996CN1135180A Use of penciclorin for the treatment of post-therapeutic neuralgia
11/06/1996CN1135179A Hydroxyl ions as unique therapeutic agent and compounds that modulate these ions, compositions employing these agents, therapeutic method
11/06/1996CN1135178A Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or doner, or a nitric oxide inhibitor
11/06/1996CN1135177A Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
11/06/1996CN1135176A Combination of progresterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for perio-and post menopausal women
11/06/1996CN1135173A Desquamation compositions containing salicylic acid and zwitterionic compounds
1 ... 6862 6863 6864 6865 6866 6867 6868 6869 6870 6871 6872 6873 6874 6875 6876 6877 6878 6879 6880 6881 6882 ... 7860